$IBB Recent News More records for U.S. stocks as Dow

New Post Public Reply Private Reply Replies (0) Message Board

Jan 3, 2015 at 12:31 PM

$IBB Recent News

More records for U.S. stocks as Dow tops 18,000 for first time 4:05 p.m. Dec. 23, 2014 - Anora Mahmudova
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 spikes from major support 11:32 a.m. Dec. 11, 2014 - Michael Ashbaugh
Charting the latest slow-motion breakout attempt 11:22 a.m. Dec. 4, 2014 - Michael Ashbaugh
Strong bull trend reaches uncharted territory 11:51 a.m. Nov. 25, 2014 - Michael Ashbaugh
Strong bull trend reaches uncharted territory 11:29 a.m. Nov. 25, 2014 - Michael Ashbaugh
The trouble with fundamentals 1:38 p.m. Nov. 11, 2014 - The Trading Deck
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
S&P, Nasdaq within striking distance of 50-day average 10:22 a.m. Oct. 24, 2014 - Michael Ashbaugh
Broadly-based snapback strengthens bull case 10:10 a.m. Oct. 22, 2014 - Michael Ashbaugh
U.S. stocks jump; Nasdaq enjoys best day in 21 months 3:38 p.m. Oct. 21, 2014 - Anora Mahmudova
U.S. benchmarks hesitate at major resistance 9:26 a.m. Oct. 20, 2014 - Michael Ashbaugh
Charting a failed retest of the 200-day average 10:16 a.m. Oct. 15, 2014 - Michael Ashbaugh
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 7:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Charting the October technical breakdown 10:06 a.m. Oct. 2, 2014 - Michael Ashbaugh
Charting the S&P 500’s precarious posture 9:44 a.m. Sept. 25, 2014 - Michael Ashbaugh
Nasdaq balks at the September peak 9:40 a.m. Sept. 22, 2014 - Michael Ashbaugh
U.S. stocks end lower; tech and small-caps lead losses 3:09 p.m. Sept. 15, 2014 - Anora Mahmudova
Stock-picking gains traction as volatility looms 5:01 a.m. Sept. 7, 2014 - Wallace Witkowski

Why the Next Week of Trading is Crucial 8:06 p.m. Jan. 1, 2015 - InvestorPlace.com
Low-Volume Pullback Looks Like History Repeating 8:43 p.m. Dec. 30, 2014 - InvestorPlace.com
Healthcare Stocks Pause, Is Biotech Boom Over? 11:16 a.m. Dec. 30, 2014 - Barrons.com
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially 7:05 a.m. Dec. 30, 2014 - Seeking Alpha
Analyzing The First Trust Health Care AlphaDEX ETF: How Did It Do It? 11:40 a.m. Dec. 29, 2014 - Seeking Alpha
TherapeuticsMD Is a Top Stock Under $10 for 2015: David Peltier 10:35 a.m. Dec. 29, 2014 - TheStreet.com
Biotech Weekly: Charts And Themes Present Mildly Bullish Outlook Into 2015 8:13 a.m. Dec. 29, 2014 - Seeking Alpha
Market Makes New Highs, but Inconsistencies Are Troubling 8:20 p.m. Dec. 28, 2014 - InvestorPlace.com
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers 9:33 a.m. Dec. 24, 2014 - Seeking Alpha
Why I Expect The Biotech Sell-Off To Continue Into 2015 8:08 a.m. Dec. 24, 2014 - Seeking Alpha
Cramer's Mad Money - Navigator Holdings Has Been Unfairly Punished (12/23/14) 5:37 a.m. Dec. 24, 2014 - Seeking Alpha
Bulls Rejoice Dow 18,000, but Maybe Not for Long 8:51 p.m. Dec. 23, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Here Are 10 Stocks to Buy on Strong GDP Data 8:26 p.m. Dec. 23, 2014 - TheStreet.com
Investors Should Stay Long Stocks as Market Continues Hitting Highs 3:01 p.m. Dec. 23, 2014 - TheStreet.com
Inside The 2 New Innovative Biotech ETFs From BioShares 3:00 p.m. Dec. 23, 2014 - Seeking Alpha
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary 12:02 p.m. Dec. 23, 2014 - Zacks.com
Inside the Two New Innovative Biotech ETFs from BioShares - ETF News And Commentary 8:02 a.m. Dec. 23, 2014 - Zacks.com
Making Money With Charles Payne: 12/22/14 6:00 p.m. Dec. 22, 2014 - FOXBusiness
Abbvie Versus Gilead In Hepatitis C, With Comments On Biotech 2:09 p.m. Dec. 22, 2014 - Seeking Alpha
No Bargains in Rising Market: Why Not Buy High and Sell Higher? 12:29 p.m. Dec. 22, 2014 - TheStreet.com

GW Pharmaceuticals Added to NASDAQ Biotechnology Index 2:00 a.m. Dec. 22, 2014 - GlobeNewswire
Hyperion Therapeutics Added to Nasdaq Biotechnology Index (NBI) 4:06 p.m. Dec. 18, 2014 - GlobeNewswire
Revance Therapeutics Added to NASDAQ Biotechnology Index 4:06 p.m. Dec. 18, 2014 - GlobeNewswire
Cara Therapeutics Announces Addition to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 18, 2014 - GlobeNewswire
Relypsa to be Added to NASDAQ Biotechnology Index 8:01 a.m. Dec. 17, 2014 - GlobeNewswire
Alder BioPharmaceuticals Announces Addition to NASDAQ Biotechnology Index 4:02 p.m. Dec. 16, 2014 - GlobeNewswire
Kite Pharma Added to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 16, 2014 - GlobeNewswire
Zafgen Added to NASDAQ Biotechnology Index 7:01 a.m. Dec. 16, 2014 - GlobeNewswire
Foundation Medicine to Be Added to NASDAQ Biotechnology Index 6:30 a.m. Dec. 16, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Added to NASDAQ Biotechnology Index (NBI) 6:30 a.m. Dec. 16, 2014 - BusinessWire - BZX
Cleveland Biolabs; A Diverse Play on Both Biodefense and Cancer 10:51 a.m. Nov. 13, 2014 - ACCESSWIRE
Premier Biomedical Advances Technology via Partnerships 9:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 8:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 8:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 8:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 5:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 7:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...